GE HealthCare to acquire Sofie Biosciences for $945M

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 05 Oct, 15:22 UTC

Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.

businessscience

Sources

• T2GE HealthCare to acquire Sofie Biosciences for $945MBioPharma Dive / Healthcare Dive / MedTech Dive05 Oct, 15:22